GT Biopharma Inc

+0.01 (+0.38%)
Earnings Announcements

GT Biopharma Reports Fourth Quarter Net Loss Of $18.0 Mln

Published: 03/28/2022 20:52 GMT
GT Biopharma Inc (GTBP) - Gt Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Update.
Gt Biopharma Inc - Cash and Cash Equivalents Expected to Provide Ample Runway to Fund Operations Into 2023.
Gt Biopharma Inc - for Q4 of 2021, Company Reported a Net Loss of $18.0 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.